baber/WOPTO huggingface dataset:
Patent JP-4295361-B2 (JP)
IPC: C07D277/30
Filed: 1998-06-24
Granted: 2009-07-15
Abstract: Aryl-substituted and aryl and (3-oxo-1-propenyl)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invented RAR antagonists can be administered to mammals, including humans, for the purpose of preventing or diminishing action of RAR agonists on the bound receptor sites. Specifically, the RAR agonists are administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors. The retinoid negative hormones can be used to potentiate the activities of other retinoids and nuclear receptor agonists. For example, the retinoid negative hormone called AGN 193109 effectively <CHEM> increased the effectiveness of other retinoids and steroid hormones in in vitro transactivation assays. Additionally, transactivation assays can be used to identify compounds having negative hormone activity. These assays are based on the ability of negative hormones to down-regulate the activity of chimeric retinoid receptors engineered to possess a constitutive transcription activator domain.
Patent JP-3093789-B2 (JP)
IPC: H01T4/02
Filed: 1991-03-15
Granted: 2000-10-03
Abstract: PCT No. PCT/GB91/00405 Sec. 371 Date Sep. 15, 1992 Sec. 102(e) Date Sep. 15, 1992 PCT Filed Mar. 15, 1991 PCT Pub. No. WO91/14304 PCT Pub. Date Sep. 19, 1991.A surge arrester 2 comprises eight surge arresting varistor blocks 4 stacked within a polymeric outer insulating housing 14. A fibre optic cable 16 is fed into the surge arrester 2 through one end electrode 6, helically wound around all the blocks 4 in good thermal contact therewith and exits through the same electrode 6. A monitoring arrangement 18 compares the light incident on and emergent from the optical cable 16 to determine its integrity and thus the integrity of the surge arrester 2.
Patent JP-2755823-B2 (JP)
IPC: G01N33/68
Filed: 1993-08-10
Granted: 1998-05-25
Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving testing of the body fluid concentration of an analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least part of the pre-ovulation phase of the current ovulation cycle of the individual subject, and identification from the results of such testing an analyte concentration change indicative of imminent ovulation, relative to an analyte concentration reference value that has been adapted to the individual human subject on the basis of analyte concentration test data obtained from the individual human subject during one or more previous ovulation cycles. Preferably testing for said analyte concentration during the current ovulation cycle is commenced a plurality of days (preferably at least 5) following the onset of menses but at least 2 numerical days in advance of the earliest numerical day on which actual ovulation has occurred in one or more previous ovulation cycles in the same individual subject.
Patent JP-2780063-B2 (JP)
IPC: A23L7/10
Filed: 1994-07-28
Granted: 1998-07-23
Abstract: The invention concerns rye-flours with either less than 7 wt% protein or with more than 12 wt% protein. These flours can be obtained as the result of classification of rye-flour with 7-12 wt% protein.
Patent JP-2549305-B2 (JP)
IPC: G01N33/543
Filed: 1988-08-05
Granted: 1996-10-30
Abstract: The present invention provides a test strip (10) for detecting, in a sample from a human subject, the presence of an antigenic substance which comprises a solid support (11), the antigenic substance bound to a first discrete area (14) on the solid support (11), an anti-human antibody bound to a second discrete area (15) on the solid support (11) as a positive control, and an antibody directed against an antigen which does not naturally occur in human subjects bound to a third discrete area (12) on the solid support (11) as a negative control. The invention additionally provides a test strip (21) for detecting, in a sample from a human subject, the presence of an antigenic substance which comprises a solid support (11), an antibody-based reagent directed against the antigenic substance in an immune complex and native human antibody thereto bound to a first discrete area (24) on the solid support (11), an anti-human antibody bound to a second discrete area (15) on the solid support (11) as a positive control, and an antibody directed against an antigen which does not naturally occur in human subjects bound to a third discrete area (12) on the solid support (11) as a negative control. The invention also provides for a method for detecting in a sample from a human subject the presence of an antigenic substance using the aforementioned test strips.
Patent JP-3896163-B2 (JP)
IPC: A61B5/103
Filed: 1997-06-30
Granted: 2007-03-22
Abstract: Method and apparatus for venous compression plethysmography with a strain-gauge or by direct circumferential length measurement, the calibration of the measurement equipment being done automotively.
Patent JP-2513449-B2 (JP)
IPC: B26B19/06
Filed: 1993-09-27
Granted: 1996-07-03
Abstract: A shaving system includes a platform member (30) with a support surface (36) that has a plurality of apertures (50A-50D) therein and guard structure (34) integral therewith and disposed forwardly of the support surface, a cap member (44) with a plurality of post elements (76A-76D) for disposition in the apertures in the support structure, a primary blade member (38) having a planar body and a cutting edge (60P), a secondary blade member (40) having a planar body and a cutting edge (60S), each blade member having a plurality of apertures (62A-62D) and at least two of the apertures having spaced locating surfaces for positioning engagement with the post elements, and a plurality of discrete spacer members (42A-42D) disposed on the post elements and between the primary and secondary blade members. The post elements extend through the apertures in the blade members, the spacers and the platform member and preferably are mechanically deformed to secure the primary and secondary blade members with their cutting edges in spaced parallel relation in a fixed shaving geometry. The spacer members maintain predetermined vertical spacing between the cutting edges of the primary and secondary blade members and the post elements maintain predetermined lateral spacing of the blade edges of the primary and secondary blade members relative to the guard structure. <IMAGE>
Patent JP-3183887-B2 (JP)
IPC: B22D11/06
Filed: 1993-11-22
Granted: 2001-07-09
Abstract: PCT No. PCT/AU93/00593 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Nov. 22, 1993 PCT Pub. No. WO95/09110 PCT Pub. Date Apr. 6, 1995.Method and apparatus for continuously casting metal strip (20) of the kind in which a casting pool of molten metal (30) is formed in contact with a moving casting surface. By making the casting surface (16A) very smooth and inducing relative vibratory movement between the molten metal and the casting surface at selected frequency and amplitude, the heat transfer from the solidifying metal is dramatically improved. The casting surface has an Arithmetical Mean Roughness Value (Ra) of less than 5 microus and the induced vibratory movement preferably has a frequency of no more than 20 kHz. This enables improved casting productivity and also produced a marked refinement of the surface structure of the cast metal.
Patent JP-2879975-B2 (JP)
IPC: C12R1/91
Filed: 1993-12-10
Granted: 1999-04-05
Abstract: PCT No. PCT/EP93/03499 Sec. 371 Date Aug. 16, 1994 Sec. 102(e) Date Aug. 16, 1994 PCT Filed Dec. 10, 1993 PCT Pub. No. WO94/13795 PCT Pub. Date Jun. 23, 1994The invention relates to a monoclonal antibody AT 120 which forms an immunological complex with an epitope of an antigen belonging to normal human tau protein as well as abnormally phosphorylated human tau protein, with said tau protein being liable to be obtained from a brain homogenate, itself isolated from human cerebral cortex. The monoclonal antibodies of the invention can be used to detect tau and abnormally phosphorylated tau in brain extracts and in unconcentrated cerebrospinal fluid.
Patent JP-3362847-B2 (JP)
IPC: C12R1/07
Filed: 1991-08-06
Granted: 2003-01-07
Abstract: The invention relates to serine protease variants derived from precursor serine proteases via recombinant and/or chemical methods to form protease variants having improved peptide ligase activity. The invention also includes novel ligation substrates which in combination with the serine protease variants and a second ligation substrate are capable of forming a ligation product. The invention also relates to methods for forming such ligation products and the products formed thereby.
Patent JP-3540323-B2 (JP)
IPC: B01L3/00
Filed: 1995-11-06
Granted: 2004-07-07
Abstract: The invention relates to body fluid testing to separate cells or other components of body fluid for appropriate testing or analysis. Hitherto, such as blood testing, has required considerable skill and considerable care in blood sample preparation, and in other areas such as the testing of foetal abnormality has predominately involved invasive techniques, frequently to the discomfort of the mother. The object of the invention is to overcome those disadvantages mentioned above, which objective is met by a means comprising at least one first chamber, a cooperating filter extending across the or each first chamber, at least one second chamber respectively to cooperate with the at least one first chamber, and one or both of said first and second chambers having a connection to vacuum. <IMAGE>
Patent JP-3059222-B2 (JP)
IPC: C11D7/54
Filed: 1996-12-13
Granted: 2000-07-04
Abstract: Liquid aqueous bleaching compositions are disclosed which comprise a pH buffering means with low sensitivity to water hardness and an alkali metal hypochlorite. A method of treating fabrics with said compositions is also disclosed.
Patent JP-4293570-B2 (JP)
IPC: C08J3/12
Filed: 1998-01-08
Granted: 2009-07-08
Abstract: The invention relates to a new, particularly economic process for preparing pulverulent polysaccharide derivatives, in particular cellulose derivatives, having a thermal flocculation point; the process comprises soaking or dissolving the polysaccharide derivative in a solvent or mixed solvent, dividing/comminuting the soaked or dissolved polysaccharide derivative by thermal and/or mechanical liquid separation and an optional drying step.
Patent JP-4086324-B2 (JP)
IPC: C12N5/10
Filed: 1998-02-17
Granted: 2008-05-14
Abstract: NTNR alpha , NTNR alpha  extracellular domain (ECD), NTNR alpha variants, chimeric NTNR alpha  (e.g., NTNR alpha  immunoadhesion), and antibodies which bind thereto (including agonist and neutralizing antibodies) are disclosed. Various uses for these molecules are described, including methods to modulate cell activity and survival by response to NTNR alpha -ligands, for example NTN, by providing NTNR alpha  to the cell.
Patent JP-4035642-B2 (JP)
IPC: C07F9/6506
Filed: 1997-04-01
Granted: 2008-01-23
Abstract: PCT No. PCT/US97/05307 Sec. 371 Date Oct. 15, 1998 Sec. 102(e) Date Oct. 15, 1998 PCT Filed Apr. 1, 1997 PCT Pub. No. WO97/41132 PCT Pub. Date Nov. 6, 1997An improved process for the preparation of a diester of phosphoric acid 2,5-dioxo-4, 4-diphenyl-imidazolidin-1-ylmethyl ester is described where an alkali metal phosphate is treated with a 3-(chloromethyl)- or 3-(bromomethyl)-5,5-diphenyl-2,4-imidazolidinedione to afford the desired product, as well as valuable intermediates used in the process.
Patent ES-2336733-B2 (ES)
Title: Cierre para tapas de contenedores soterrados.
Inventor: BALERDI ETXANIZ MODESTO
IPC: B65F1/14
Filed: 2007-03-30
Granted: 2011-01-27
Abstract: Cierre para tapas de contenedores soterrados,
que consta de un espárrago (4) accionado por llave (3); una lengüeta
(5) montada sin giro en dicho espárrago (4); un soporte (9) fijo al
marco (2) de la tapa en el que se dispone el conjunto espárrago
(4)/lengüeta (5) y un cerradero (6), fijo a la pared de la arqueta,
en el que se traba/libera la lengüeta (5) al alcanzar dos posiciones
extremas de cierre/apertura girando la llave (3), con medios para
impedir la extracción de la llave (3) cuando el cierre no está en
posición cerrada.
Patent ES-2304878-B2 (ES)
Title: Boya para el fondeo y el suministro de servicios a embarcaciones de recreo.
Inventor: BAEZA OCHOA DE OCARIZ RODRIGO
IPC: B63B22/02
Filed: 2007-04-02
Granted: 2009-09-11
Abstract: Boya para el fondeo y el suministro de servicios
a embarcaciones de recreo, cuyos  elementos principales son: un
cuerpo; una argolla inferior a la que se une una cadena  que termina
en otra argolla superior de un muerto que descansa en el lecho
marino;  una argolla superior retráctil de amarre; un elemento
satélite extraíble, con el que  se pueden llevar hasta las
embarcaciones unas mangueras de agua potable y de  corriente
eléctrica unidas a un ramal de una red de distribución de
suministros que,  desde un armario de acometidas situado en tierra,
llega a la boya, ramal que sube  unido con abrazaderas a la cadena
de amarre de aquélla, pudiendo  enrollarse/desenrollarse, tanto las
mangueras como un cable acerado de seguridad,  sobre un tambor
giratorio ubicado en el interior de la boya. Aplicable junto a los 
puertos deportivos, calas o espacios marítimos similares para
aumentar la oferta de  plazas de amarre.
Patent ES-2377619-B2 (ES)
Title: Fotobioreactor para el cultivo a gran escala de microalgas.
Inventor: LEE CHOUL-GYUN
IPC: C12M1/00
Filed: 2008-11-28
Granted: 2013-10-30
Abstract: Un fotobioreactor para el cultivo a gran escala de microalgas. El fotobioreactor incluye una gran variedad de estaciones de fuente de luz superficial utiliza un elemento de diodo emisor de luz (LED), un elemento de diodo emisor de luz orgánico (OLED), o una lámina de LED flexible como fuente de luz. Las estaciones de fuente de luz superficial tienen forma de placa plana o de cilindro, se instalan a intervalos predeterminados en el espacio interior de un tanque de reacción con forma cuboide o cilíndrica, y emiten luz para el cultivo de microalgas de modo que están iluminadas desde el interior. Aquí, las estaciones de fuente de luz superficial se instalan de forma que están alternativamente en contacto con la primera y la segunda pared del tanque de reacción dispuestas en paralelo entre ellas de forma simétrica, y sirven como compartimentos que compartimentan el espacio interior del tanque de reacción y aumentan la distancia de flujo del gas.
Patent ES-2503893-B2 (ES)
Title: Sistema y método de estimación de resistencia de defecto ante faltas a tierra en devanados rotóricos de máquinas síncronas
Inventor: ARANDA RUIZ MARÍA
IPC: G01R31/06
Filed: 2014-03-05
Granted: 2015-01-20
Abstract: Método de estimación de resistencia de falta ante faltas a tierra en devanados rotóricos de máquinas síncronas.#La presente invención permite la estimación de la resistencia de falta ante defectos a tierra en devanados rotóricos de máquinas síncronas alimentados mediante rectificadores conectados a un transformador. El método presenta la ventaja de poder conocer la magnitud del problema que afecta a la máquina, ya que cuanto mayor sea la resistencia de falta, menor será la corriente de defecto.#La estimación se basa principalmente en el análisis de las componentes armónicas de la tensión en la resistencia de puesta a tierra.
Patent ES-2642773-B2 (ES)
Title: Sistema de ensamblaje entre conjuntos de una carrocería de un vehículo
Inventor: SEGURA SANTILLANA ANGEL
IPC: B62D27/00
Filed: 2016-12-30
Granted: 2018-05-28
Abstract: Sistema de ensamblaje entre conjuntos de una carrocería (5) de un vehículo (1), donde el sistema de ensamblaje comprende al menos un medio de unión (6) de un componente (3) con la carrocería (5), con un orificio (61), atravesado por al menos un tornillo (62), que sujeta el al menos un medio de unión (6) con la carrocería (5), el tornillo (62) comprende un vástago (621) y una cabeza (622), el orificio (61) permite guiar el al menos un tornillo (62) en la dirección sustancialmente vertical, y comprende una primera anchura (614) en la dirección sustancialmente horizontal, igual al diámetro del vástago (621), y una segunda anchura (615) es substancialmente superior al diámetro del vástago (621). Así se amortigua el impacto sufrido por un peatón, en particular en la zona del capó y del guardabarros, absorbiendo energía del choque, reduciendo la energía recibida por parte del peatón.
Patent IE-S86489-B2 (IE)
Title: Water storage shed
Inventor: SQUIRES ROBERT LAURENCE
IPC: E04H7/00
Filed: 2013-10-16
Abstract: A portable water storage shed (1) comprises a rigid base (2), upstanding side walls (3) on the base (2) and a roof (4) on top of the side walls (3). A doorway in one of the side walls (3) provides access to an interior of the shed (1). A number of water storage tanks are mounted in the base (2) and side walls (3) of the shed (1) to collect water run-off from the roof (4). A main water storage tank (5) is mounted within the base (2). Ancillary water storage tanks (6,7,8) are mounted within the side walls (3) at each side and at a rear of the shed (1). All of the ancillary water storage tanks (6,7,8) and the main water storage tank (5) are interconnected by pipework such that water in the ancillary water storage tanks (6,7,8) will feed under gravity from the ancillary water storage tanks (6,7,8) into the main water tank (5). A water outlet (11) on the main water storage tank (5) is connected to a pump (12) for discharging water from the storage tanks (5,6,7,8) for use in the home or garden for example. <Figure 1>
Patent AU-2001264853-B2 (AU)
Title: Configurable vacuum system and method
Inventor: HOPKINS DANIEL N
IPC: C23C14/32
Filed: 2001-05-22
Granted: 2005-09-15
Abstract: An exemplary configurable vacuum system and method are provided for use in coating or plating that provides the capability to handle substrates of significantly different shapes and sizes. The configurable vacuum system includes a vacuum table assembly and a vacuum chamber. The vacuum table assembly may include a support frame, an insulated surface, a mechanical drive mounted to the support frame, an electrical feed through mounted to the support frame, a filament positioned above the insulated surface between a first filament conductor and a second filament conductor, a filament power connector electrically coupled to the first filament conductor through a first filament power contact pad of the filament power connector and to the second filament conductor through a second filament power contact pad of the filament power connector, and a platform operable to support the substrate. The vacuum chamber may include a vacuum chamber having a main opening at a door, a wall that defines an interior volume, a filament power connector, an electrical feed through connector, a mechanical drive connector, a railing operable to receive and support the vacuum table assembly within the internal volume of the vacuum chamber. The various connectors of the vacuum table assembly and vacuum chamber may automatically couple with one another.
Patent AU-2001279535-B2 (AU)
Title: Bone-regeneration material
Inventor: STOLL THIERRY
IPC: A61L27/12
Filed: 2001-08-13
Granted: 2004-06-17
Abstract: The invention relates to a process for producing a bone-regeneration material. According to the method, a bio-compatible, open-pored body is exposed to a vacuum and osteoinductive and/or osteogenic substances are absorbed into the pores of the body, for example by means of a vacuum generated therein. It is thus possible to produce a bone-regeneration material, which contains osteoinductive and/or osteogenic substances in the pores of the bio-compatible body, said substances acting as a network structure for new somatic cells that are to grow into the porous body.
Patent AU-2002218502-B2 (AU)
Title: Lactam compounds and medicinal use thereof
Inventor: HIRAMA RYUSUKE
IPC: C07D243/10
Filed: 2001-11-29
Granted: 2006-09-21
Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
Patent AU-2002224317-B2 (AU)
Title: Process for preparing pharmaceutical compositions for use with soft gelatin formulations
Inventor: FERDINANDO JOSEPHINE CHRISTINE
IPC: A61K31/167
Filed: 2001-08-28
Granted: 2004-09-02
Abstract: The invention disclosed herein is a process for increasing the achievable concentration of a pharmaceutically active ingredient relative to fill composition viscosity for dosage units. The process is particularly useful in the preparation of soft gelatin capsules containing ibuprofen, naproxen, indomethacin, and acetaminophen, as the pharmaceutically active ingredient. As a result of the process, lesser quantities of composition ingredients other than the pharmaceutically active ingredient are needed to accomplish the same therapeutically effective dosage, thereby significantly increasing the concentration of the pharmaceutically active ingredient resulting in either a reduction in overall fill volume and dosage unit size or an increase in concentration of pharmaceutically active ingredient per dosage form.
Patent AU-2002241085-B2 (AU)
Title: Processes using metal bis-triflimide compounds
Inventor: THOMSON JILLIAN M
IPC: C07F1/08
Filed: 2002-03-12
Granted: 2007-03-29
Abstract: Process for producing metal bis-triflimide compounds having the formula: 
[M x ] n+  [(N(SO 2 CF 3 ) 2 ) (nx-yz) ]  (nx-yz)-  [L y ] z-  wherein M is a metal selected from the metals in groups 5 to 10, 12 and 14 to 16 and Cu, Au, Ca, Sr, Ba, Ra, Y, La, Ac, Hf, Rf, Ga, In, Tl, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Lu and the actinides; 
L is a negative or neutral ligand; n is 2, 3, 4, 5, 6, 7 or 8; x is greater than or equal to 1; y is 0, 1, 2, 3, 4, 5, 6, 7 or 8; and z is 0, 1, 2, 3 or 4.
Patent AU-2002329991-B2 (AU)
Title: Methods for in vivo evaluation of a physiological structure or function using polarized 129Xe
Inventor: MARELLI CLAUDIO
IPC: A61B5/08
Filed: 2002-09-06
Granted: 2008-09-25
Abstract: In certain embodiments, methods of the present invention obtain dynamic data sets of an NMR spectroscopy signal of polarized 129Xe in a selected structure, environment, or system. The signal data can be used to evaluate: (a) the physiology of a membrane or tissue: (b) the operational condition or function of a body system or portion thereof (when at rest or under stimulation); and/or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and/or diagnosing a respiratory, cardiopulmonary disorder or disease such as chronic heart failure, and/or methods for monitoring the efficacy of therapeutics administered to subject to treat the disorder or disease.
Patent AU-2002356575-B2 (AU)
Title: Endoprosthesis for vascular bifurcation
Inventor: SEGUIN JACQUES
IPC: A61F2/954
Filed: 2002-11-08
Granted: 2009-07-16
Abstract: A system for delivering an apparatus (1) for treating an area of bifurcation where a principal body conduit separates into at least two secondary conduits and wherein the principal conduit increases in cross section to the junction with the secondary conduits, said system comprising positioning equipment (15,16) and the apparatus, and the apparatus comprising an expandable first stent body configured to be engaged in the primary conduit in the area of bifurcation (11).
Patent AU-2003213043-B2 (AU)
Title: Papermaker's Nip Thickening Fabric
Inventor: ZILKER GREGORY D
IPC: D21F1/10
Filed: 2003-02-13
Granted: 2007-08-16
Abstract: A papermaker's fabric for use on a pulp thickening device and the like, having a body with edge portions on which are located guides with transition points between the body, and edge portions being reinforced with a coating that extends from the edge portions over the transition points onto the body.